Ahead of print

Review

Preserflo MicroShunt – A Modern Microinvasive Approach in the Surgical Treatment of Glaucoma. A Review

Petra Kéri ORCID
Lucia Herdová ORCID – Adriana Takáčová ORCID – Nora Majtánová ORCID

Full Text links

Keywords: glaucoma, microinvasive glaucoma surgery, Preserflo MicroShunt, intraocular pressure, drainage implant

Summary

Preserflo MicroShunt (Santen Pharmaceutical, Osaka, Japan) is a new drainage implant designed for controlling intraocular pressure (IOP) in patients with open-angle glaucoma in cases where conservative therapy has failed. The implant, made of biocompatible SIBS material, drains aqueous humor from the anterior chamber to the sub-Tenon’s space, ensuring the long-term reduction of IOP. This review article summarizes the available clinical and experimental data on the Preserflo MicroShunt, compares its efficacy and safety to traditional trabeculectomy, and defines its role within the current glaucoma surgery algorithm.

References

  1. Balas M, Mathew DJ. Minimally Invasive Glaucoma Surgery: A Review of the Literature. Vision (Basel). 2023 Aug 21;7(3):54.
  2. Prokosch V, Dietlein T, Pfeiffer N. Neue und alte Verfahren der Glaukomchirurgie im Vergleich : Trabekulektomie, PreserFlo und XEN [Comparison of new and old procedures in glaucoma surgery: Trabeculectomy, Preserflo and XEN]. Ophthalmologie. 2023 Apr;120(4):350-357. German.
  3. Khan A, Khan AU. Comparing the safety and efficacy of Preserflo Microshunt implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis. Acta Ophthalmol. 2024 Jun;102(4):e443-e451.
  4. Gambini G, Carlà MM, Giannuzzi F, et al. PreserFlo® MicroShunt: An Overview of This Minimally Invasive Device for Open-Angle Glaucoma. Vision (Basel). 2022 Feb 9;6(1):12.
  5. Batlle JF, Fantes F, Riss I, et al. Three-Year Follow-up of a Novel Aqueous Humor MicroShunt. J Glaucoma. 2016 Feb;25(2):e58-65.
  6. Saeed E, Gołaszewska K, Dmuchowska DA, Zalewska R, Konopińska J. The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review. Int J Environ Res Public Health. 2023 Feb 7;20(4):2904.
  7. Jamke M, Herber R, Haase MA, Jasper CS, Pillunat LE, Pillunat KR. PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol. 2023 Oct;261(10):2901-2915.
  8. Hasan SM, Theilig T, Meller D. Comparison of Bleb Morphology following PRESERFLO® MicroShunt and Trabeculectomy Using Anterior Segment OCT. Diagnostics (Basel). 2023 Nov 2;13(21):3373.
  9. Majtanova N, Takacova A, Kurilova V, Hejsek L, Majtan J, Kolar P. One-Year Comparison of Efficacy and Safety of PreserFlo MicroShunt with Mitomycin C Applied by Sub-Tenon Injection Versus Sponge. Ophthalmol Ther. 2025 Jan;14(1):153-167.
  10. Pawiroredjo SSM, Bramer WM, Pawiroredjo ND, et al. Efficacy of the PRESERFLO MicroShunt and a Meta-Analysis of the Literature. J Clin Med. 2022 Dec 1;11(23):7149.
  11. Pillunat KR, Herber R, Haase MA, Jamke M, Jasper CS, Pillunat LE. PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol. 2022 May;100(3):e779-e790.
  12. Prokosch V, Dietlein T, Pfeiffer N. Neue und alte Verfahren der Glaukomchirurgie im Vergleich : Trabekulektomie, PreserFlo und XEN [Comparison of new and old procedures in glaucoma surgery : Trabeculectomy, Preserflo and XEN]. Ophthalmologie. 2023 Apr;120(4):350-357. German.
  13. Tanner A, Haddad F, Fajardo-Sanchez J, et al. One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis. Br J Ophthalmol. 2023 Aug;107(8):1104-1111.
  14. Scheres LMJ, Kujovic-Aleksov S, Winkens B, de Crom RMPC, Webers CAB, Beckers HJM. Five-year follow-up with the PreserFlo MicroShunt for open-angle glaucoma. Eye (Lond). 2025 Jun;39(8):1540-1546.
  15. Governatori L, Oliverio L, Mermoud A, et al. PreserFlo MicroShunt versus trabeculectomy: an updated meta-analysis and systematic review. Graefes Arch Clin Exp Ophthalmol. 2025 Apr;263(4):885-
  16. Zweifel LAB, Storp JJ, Vietmeier FE, et al. Preserflo MicroShunt versus Trabeculectomy: Efficacy and Surgical Success within a Heterogenous Patient Cohort. Life (Basel). 2024 Sep 17;14(9):1171.